Research Partners

xCures has partnered to make the xINFORM patient portal available to PanCAN’s Patient Services program and longitudinal clinical data from the xCures database accessible to PanCAN’s grantees and clinical researchers

xCures has partnered with the Critical Path Institute and the CURE Drug Repurposing Collaboratory (CDRC) to search for efficacious uses of repurposed drugs by generating regulatory-compliant real-world data in sarcomas

xCures has partnered with the DIPG and DMG Research Funding Alliance (DDRFA) to support the recruitment of patients with these rare CNS cancers into a natural history study (xPedite) with the
ultimate goal of ending randomization in clinical trials.

The FibroFighters Foundation and xCures have partnered to create a complete longitudinal clinical data registry in fibrolamellar carcinoma, a rare form of liver cancer primarily affecting adolescents and young adults.